Current devices for pediatric extracorporeal life support and mechanical circulatory support systems in the United

Akif Undar1, Shigang Wang

  • 1Penn State Hershey Pediatric Cardiovascular Research Center, Department of Pediatrics, Penn State Milton S. Hershey Medical Center, Penn State Hershey College of Medicine, Penn State Hershey Children's Hospital, Hershey, PA 17033-0850, USA. aundar@psu.edu

Insights

Extracorporeal life support (ECLS) and mechanical circulatory support (MCS) are vital for pediatric heart defects. This review covers current ECLS and MCS devices in the US for treating heart and lung failure in children.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Biomedical Engineering

Background:

  • Extracorporeal life support (ECLS) and mechanical circulatory support (MCS) are critical interventions for pediatric patients with congenital heart defects experiencing heart or lung failure.
  • These support systems serve as crucial bridges to recovery, transplantation, destination therapy, or long-term mechanical support.

Purpose of the Study:

  • To review and discuss the currently available devices for pediatric ECLS and MCS in the United States.
  • To highlight the importance of appropriate device selection and cannulation strategies in pediatric patients.

Main Methods:

  • Literature review of current ECLS and MCS devices used in pediatric care.
  • Discussion of device selection criteria based on patient condition and support type (e.g., V-A ECMO, V-V ECMO, uni-/biventricular MCS).

Main Results:

  • Various ECLS and MCS devices are available for pediatric use, offering tailored support for different failure types.
  • Careful consideration of patient size, access sites, cannulation, and equipment (tubing, oxygenator, pump) is essential for optimal outcomes.
  • Proper device selection minimizes injury and facilitates early support, reducing device-related complications.

Conclusions:

  • The appropriate selection and application of ECLS and MCS devices are paramount for successful management of pediatric heart and lung failure.
  • Optimizing device characteristics and cannulation techniques improves patient outcomes and reduces morbidity and mortality in this vulnerable population.